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Abstract
Tonic inhibition mediated by extrasynaptic GABAA receptors (GABAARs) is an important regulator of neuronal excitability. Phos-
phorylation by protein kinase C (PKC) provides a key mode of regulation for synaptic GABAARs underlying phasic inhibition; how-
ever, less attention has been focused on the plasticity of tonic inhibition and whether this can also be modulated by receptor
phosphorylation. To address this issue, we used whole-cell patch clamp recording in acute murine brain slices at both room and
physiological temperatures to examine the effects of PKC-mediated phosphorylation on tonic inhibition. Recordings from dentate
gyrus granule cells in the hippocampus and dorsal lateral geniculate relay neurons in the thalamus demonstrated that PKC activa-
tion caused downregulation of tonic GABAAR-mediated inhibition. Conversely, inhibition of PKC resulted in an increase in tonic
GABAAR activity. These findings were corroborated by experiments on human embryonic kidney 293 cells expressing recombi-
nant a4b2d GABAARs, which represent a key extrasynaptic GABAAR isoform in the hippocampus and thalamus. Using bath appli-
cation of low GABA concentrations to mimic activation by ambient neurotransmitter, we demonstrated a similar inhibition of
receptor function following PKC activation at physiological temperature. Live cell imaging revealed that this was correlated with a
loss of cell surface GABAARs. The inhibitory effects of PKC activation on a4b2d GABAAR activity appeared to be mediated by
direct phosphorylation at a previously identified site on the b2 subunit, serine 410. These results indicate that PKC-mediated
phosphorylation can be an important physiological regulator of tonic GABAAR-mediated inhibition.
Introduction
GABAA receptors (GABAARs) mediate two forms of inhibition
within the brain, phasic and tonic (Farrant & Nusser, 2005). Phasic
inhibition is mostly mediated by c2 subunit-containing GABAARs
located at inhibitory synapses that are activated by exocytotic
GABA release, resulting in brief inhibitory postsynaptic currents
(IPSCs). By contrast, tonic inhibition requires extrasynaptic a4/6d or
a5 subunit-containing GABAARs that are activated by ambient
GABA concentrations, providing a persistent tonic membrane
conductance. Tonic conductances are found in various brain regions,
and are important for the control of neuronal excitability both in
vitro (Brickley et al., 1996; Mitchell & Silver, 2003; Bright et al.,
2007; Pavlov et al., 2009) and in vivo (Chadderton et al., 2004;
Duguid et al., 2012). Indeed, dysfunctional tonic GABAAR-medi-
ated inhibition is associated with various pathological conditions
(Brickley & Mody, 2012), including, epilepsy (Zhan & Nadler,
2009), schizophrenia (Damgaard et al., 2011), depression (Merali
et al., 2004), and fragile X syndrome (Olmos-Serrano et al., 2010).
Whereas various mechanisms that regulate the efﬁcacy of synaptic
inhibition have been identiﬁed (Olmos-Serrano et al., 2010;
Cherubini, 2012), our knowledge regarding the modulation of tonic
inhibition is far less complete. A key mode of regulation for synap-
tic GABAARs is via phosphorylation of substrate sites on b1–3 and
c2 subunits by both serine/threonine and tyrosine kinases (Moss
et al., 1995; Vithlani et al., 2011). This covalent modiﬁcation can
directly change the functional properties of GABAARs, such as open
probability (Moss et al., 1995) and desensitization kinetics (Jones &
Westbrook, 1997), as well as altering their trafﬁcking at inhibitory
synapses (Vithlani et al., 2011). Indeed, kinases and phosphatases
represent critical downstream effectors for various pathways that
converge to modify inhibitory synaptic transmission (Luscher et al.,
2011).
Recent studies have shown that speciﬁc extrasynaptic GABAARs
responsible for tonic inhibition are also substrates for phosphoryla-
tion by serine/threonine kinases. Protein kinase C (PKC) phospho-
rylates a novel site, Ser443, on a4 subunits to enhance the surface
stability of a4b3 GABAARs expressed in human embryonic kidney
293 (HEK293) cells and prevent GABA-activated current run-down
(Abramian et al., 2010). In addition, Ca2+/calmodulin-dependent
protein kinase II has been implicated in the regulation of extrasy-
naptic GABAARs (Houston et al., 2007; Saliba et al., 2012).
Activation of L-type voltage-gated Ca2+ channels in cultured hippo-
campal neurons enhances Ca2+/calmodulin-dependent protein kinase
II-mediated phosphorylation at a previously identiﬁed site on the
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b3 subunit, Ser383 (Houston et al., 2007), resulting in increased
surface expression of a5b3c2 GABAARs and increased tonic cur-
rent.
Here, we examined tonic inhibitory plasticity and its regulation
by phosphorylation in dentate gyrus granule cells (DGGCs), which
provide a gateway to the hippocampal neural network, and in tha-
lamic relay neurons within the dorsal lateral geniculate nucleus
(dLGN), which form a key component of the visual system. Both
populations of neurons express tonic inhibitory currents that are lar-
gely mediated by a4bd GABAARs (Pirker et al., 2000; Cope et al.,
2005; Bright et al., 2007; Glykys & Mody, 2007; Herd et al.,
2008).
Materials and methods
Heterologous expression
HEK293 cells were cultured according to standard protocols, and
were transfected 6 h after plating. A modiﬁed calcium phosphate
method was used to introduce cDNAs encoding murine GABAAR
a4, b2 and d subunits. We used a super-ecliptic phluorin (SEP)-
tagged d subunit, which was created as previously described (Bright
et al., 2011). Expression of the d subunit was then assessed by sur-
face ﬂuorescence, altered Zn2+ sensitivity and GABA EC50 values
relative to ab expression alone (Bright et al., 2011). HEK293 cells
were used for recording after a further 16–48 h.
Acute slice preparations
Experiments were performed in compliance with the guidelines for
the welfare of experimental animals issued by the European Com-
munities Council Directive of 24 November 1986 (86/609/EEC).
Brain slices were obtained from mature (> 1 month postnatal) male
C57BL/6J mice, in accordance with the UK Animals (Scientiﬁc Pro-
cedures) Act 1986. All procedures have passed review by the UCL
Ethical Review Committee. After terminal isoﬂurane anaesthesia,
the brain was rapidly removed and then immersed in ice-cold slicing
solution composed of 85 mM NaCl, 2.5 mM KCl, 1 mM CaCl2,
4 mM MgCl2, 1.25 mM NaH2PO4, 26 mM NaHCO3, 75 mM sucrose,
and 25 mM glucose (pH 7.4 when bubbled with 95% O2 and 5%
CO2). Horizontal slices containing the ventral hippocampus or coro-
nal slices containing the dLGN (both 250 lm in thickness) were cut
with a Leica VT1200S vibroslicer. Slices were incubated at 37 °C
for 60 min, over which time the high-sucrose slicing solution was
gradually replaced with normal recording solution containing
125 mM NaCl, 2.5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 1.25 mM
NaH2PO4, 26 mM NaHCO3, and 25 mM glucose (pH 7.4 when bub-
bled with 95% O2 and 5% CO2).
Electrophysiology – recombinant receptors
Cells were perfused with a recording solution, containing 140 mM
NaCl, 2.5 mM CaCl2, 1.2 mM MgCl2, 4.7 mM KCl, 5 mM HEPES,
and 11 mM glucose; the pH was adjusted to 7.4 with 1 M NaOH.
Recordings were made either at room temperature (21–23 °C) or
near-physiological temperature (34–36 °C). The solution tempera-
ture was monitored with a miniature thermocouple in the recording
chamber. The pipette solution contained 140 mM CsCl, 2 mM NaCl,
0.5 mM CaCl2, 2 mM MgCl2, 10 mM HEPES, 5 mM EGTA, 2 mM
Na-ATP, 0.5 mM Na-GTP, and 2 mM QX-314; the pH was
adjusted to 7.3 with CsOH. Pipettes for whole-cell patch recording
were pulled from thin-walled borosilicate glass (outer diameter,
1.5 mm; inner diameter, 1.17 mm; GC-150TF-10; Harvard Appara-
tus, Kent, UK), and had a resistance of 3–5 MΩ. Currents were
recorded from green ﬂuorescent protein-ﬂuorescent cells with a
Multiclamp 700B ampliﬁer (Molecular Devices, California, USA).
To reproduce the physiological activation of d subunit GABAARs
by ambient GABA concentrations within the brain, we applied low
concentrations of GABA by bath perfusion. GABA-activated cur-
rents were allowed to reach steady state before application of other
drugs. The following drugs were bath-applied: GABA (Sigma, Dor-
set, UK), phorbol 12-myristate 13-acetate (PMA) (Calbiochem,
Middlesex, UK), and bisindolylmaleimide I (BIS-I) (Calbiochem).
Electrophysiology – acute slice preparations
Hippocampal DGGCs and thalamic relay neurons in the dLGN
were visually identiﬁed with a Nikon Eclipse F600N microscope
equipped with differential interference contrast infrared optics. Tha-
lamic relay neurons could be identiﬁed by their soma size and
input resistance; other small cells with high input resistance were
identiﬁed as local interneurons (Bright et al., 2007; Bright &
Brickley, 2008). Slices were perfused with recording solution at a
ﬂow rate of 3–4 mL/min, and this, combined with the small vol-
ume of the recording chamber (approximately 800 lL), allowed
for relatively fast solution exchange around the slice. Whole-cell
recordings were acquired under voltage clamp with a Multiclamp
700B ampliﬁer (Molecular Devices). Recording pipettes were fabri-
cated as described for HEK293 cell recordings, and ﬁlled with the
same internal solution. In some recordings, Lucifer yellow (2 mg/
mL) or biocytin (4 mg/mL) was included in the internal solution
to allow for later confocal imaging. Slices were ﬁxed after record-
ing in 4% paraformaldehyde, and in the case of biocytin-ﬁlled
cells, processed on the following day with streptavidin–Alexa
Fluor 555 (Invitrogen, Paisley, UK). Fluorescent neurons could
then be visualized with a confocal microscope (Zeiss LSM 510).
During whole-cell recording, GABAAR-mediated responses were
pharmacologically isolated by inclusion of the ionotropic glutamate
receptor blocker kynurenic acid (2 mM; Sigma) in the recording
solution. The following drugs were bath-applied: bicuculline (BIC)
(Sigma), tetrahydro-deoxycorticosterone (THDOC) (Sigma), zolpi-
dem (Sigma), PMA, and BIS-I.
Data analysis
Data acquisition was performed with PCLAMP9 (Molecular Devices).
Current records were ﬁltered at 2 kHz and digitized at 20 kHz with
a Digidata 1440A (Molecular Devices). For all recordings, the series
resistance, input resistance and capacitance were calculated from
current responses to 10-mV hyperpolarizing voltage steps. In all
cases, cells were recorded under control conditions for 5–10 min to
allow stabilization of holding current and series resistance before
application of drugs. For experiments involving pharmacological
manipulation of kinase activity, effects on phasic and tonic
inhibition were measured 15–20 min after drug application. For
experiments involving neurosteroid (THDOC) or benzodiazepine
(zolpidem) application, the drug onsets were much faster, and
measurements were therefore made 4–5 min after drug application.
Synaptic events were analysed with WINEDR/WINWCP software (John
Dempster, University of Strathclyde, Glasgow, UK). Event detection
was performed with amplitude-threshold crossing. Events were
aligned on their initial rising phases, and averaged synaptic wave-
forms were constructed from IPSCs that showed monotonic rises
and an uncontaminated decay phase (50–100 events). Average
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baseline current levels were calculated during a 10-ms epoch imme-
diately prior to each detected event, and the peak amplitude was
determined relative to this value. The 10–90% rise time was calcu-
lated between the start and the peak location, with interpolation
between samples. The decay constant of individual IPSCs was cal-
culated as the charge transfer during the baseline-corrected IPSC
divided by the IPSC peak amplitude. This allowed a ﬁt-independent
estimate of the decay that could be determined for individual or
averaged spontaneous IPSCs (sIPSCs). Phasic current was deﬁned
as the amount of charge carried by IPSCs per second, and was cal-
culated by multiplying the average charge transfer during an IPSC
by the average frequency.
The tonic GABAAR-mediated conductance was analysed in two
ways. The tonic GABAAR-mediated current was calculated from
the difference between the baseline current amplitude recorded
before and that recorded after GABAAR blockade with 20 lM BIC.
We also assessed the activity of tonically active GABAARs by mea-
suring baseline root mean square (RMS) noise. This analysis was
performed with WINEDR software. Recordings were divided into
epochs containing 2048 samples (length, 1024 ms), and epochs con-
taining synaptic currents were rejected either manually or by utiliz-
ing a running-threshold comparison in Excel. In this method, a
running average (usually the median) of the RMS noise was calcu-
lated at 5-s intervals, and epochs were rejected according to a
threshold set from this running average. This method was found to
provide an efﬁcient and reliable way of removing synaptic contami-
nation. Subsequent analysis involved calculation of the mean (syn-
aptic current-free) RMS noise over minute-long intervals and
normalization to the interval immediately prior to drug application
for each recording.
Live cell imaging of recombinant d–SEP GABAARs
HEK293 cells were transfected with cDNAs encoding murine
GABAAR a4, b2 and d–SEP subunits, as described above, and
were then used for imaging after a further 16–48 h. Transfected
cells were perfused with standard recording solution (as for the
electrophysiology experiments) at 30–32 °C, and imaged with a
Zeiss Axioskop LSM510 confocal microscope equipped with an
Achroplan 940 water immersion differential interference contrast
objective (numerical aperture, 0.8). Solutions containing GABA
(300 nM) and GABA + PMA (200 nM) were bath applied during
imaging. Fluorescence from the d–SEP subunit was revealed follow-
ing excitation with a 488-nm argon laser, and detected through a
505–530-nm bandpass ﬁlter. Images were acquired as the mean of
four scans in eight bits, with the confocal settings (detector gain,
ampliﬁer offset, and laser intensity) optimized at t = 0 and then
remaining unaltered for subsequent time points. During imaging
experiments, transmitted light images were also captured to ensure
that there were no signiﬁcant changes in cell morphology. To assess
surface ﬂuorescence of the d–SEP subunit, we applied our standard
recording solution, adjusted to pH 4.5 with HCl, to quench the ﬂuo-
rescence of the SEP moiety (Ashby et al., 2004). Confocal images
were analysed with IMAGEJ (version 1.45s) (National Institutes of
Health, Bethesda, MD, USA). The mean ﬂuorescence was deter-
mined for a region of interest (ROI) centred at the cell surface.
Background ﬂuorescence was set by imaging a region of the cover-
slip devoid of cells. This was subtracted from the ﬂuorescence for
the cell surface ROI, yielding a mean background-corrected ﬂuores-
cence. For drug application experiments, ﬂuorescence was normal-
ized to the point at which PMA was applied (5 min after GABA
application).
Statistical analysis
Statistical tests were performed with PRISM (GraphPad Software,
California, USA). Differences between groups were examined with
the appropriate paired or unpaired Student’s t-test, except where
indicated, and were considered signiﬁcant at P < 0.05. For compari-
sons of RMS noise during prolonged recordings, we used pooled
raw data and compared them with the time point immediately prior
to drug application, using paired t-tests.
Results
Tonic inhibition of DGGCs and dLGN relay neurons
Whole-cell recordings were made from visually identiﬁed hippocam-
pal granule cells within the dentate gyrus (DG) and thalamic relay
neurons within the dLGN. Both of these nuclei were easily identi-
ﬁed within the slice preparation (Fig. 1A). Some cells were ﬁlled
with either a ﬂuorescent dye (Lucifer yellow) or biocytin (see Mate-
rials and methods) to allow for later confocal imaging to check neu-
ronal location and morphological properties. Representative images
of a DGGC and a dLGN relay neuron are shown in Fig. 1B. In each
cell type, application of the GABAAR antagonist BIC (20 lM) abol-
ished sIPSCs (Fig. 1C) and reduced the holding current and baseline
noise, in accord with the presence of a tonic GABAAR-mediated
conductance.
Characterizing tonic and phasic inhibition in DGGCs at room
and physiological temperature
We recorded from mature (mean, 54 days; range, 30–100 days)
DGGCs at both room temperature (21–23 °C, 343 cells) and near-
physiological temperature (34.8  0.1 °C, 191 cells). At each tem-
perature, BIC (20 lM) reduced the holding current (Fig. 2A, B, E,
and F: room temperature, 8.6  2.1 pA, n = 22; physiological tem-
perature, 15.6  1.6 pA, n = 27). When normalized to cell capaci-
tance, this corresponds to tonic GABAAR-mediated conductances of
2.8  0.7 pS/pF (room temperature) and 4.3  0.5 pS/pF (physio-
logical temperature). Concurrent with the change in holding current,
BIC also reduced the RMS baseline noise (Fig. 2C–F: room temper-
ature, 0.41  0.05 pA, n = 22; physiological temperature, 0.63 
0.09 pA, n = 27). Notably, the change in holding current was clo-
sely correlated with the change in RMS noise at both temperatures
(Fig. 2E and F, Pearson’s correlation coefﬁcients: room temperature,
R = 0.54, P = 0.01; physiological temperature, R = 0.48, P = 0.01).
sIPSCs were conﬁrmed as being mediated by GABAARs follow-
ing blockade by BIC (Fig. 2A and B). Their properties were exam-
ined by constructing mean IPSC waveforms (see Materials and
methods; Fig. 2G and H). At physiological temperature, sIPSCs
were larger, showing faster rise and decay time kinetics, and
occurred more frequently than at room temperature (Fig. 2G and H;
Table 1).
Using RMS noise to measure tonic GABAAR-mediated
inhibition
Our recordings in DGGCs showed that the amplitude of the tonic
GABAAR-mediated current was relatively small, particularly at
room temperature (Fig. 2E and F). This is in accord with previous
studies demonstrating small tonic currents, unless the amount of
GABA in the slice is increased by either blocking GABA uptake or
by adding GABA to the recording solution (Nusser & Mody, 2002;
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Naylor et al., 2005; Mtchedlishvili & Kapur, 2006; Zhan & Nadler,
2009). Such tonic currents will be subject to measurement error, but
changes in RMS current noise may offer greater reliability for moni-
toring the activity of tonically active GABAARs (Mtchedlishvili &
Kapur, 2006; Glykys & Mody, 2007). To test the feasibility of using
RMS noise as a more reliable monitor for tonic GABAAR activity
in DGGCs, we used low concentrations of two modulators: the
neurosteroid THDOC, and the benzodiazepine zolpidem.
Application of 50 nM THDOC caused a small, but signiﬁcant,
increase in RMS noise without a discernible effect on the holding
current (Fig. 3A: change in RMS noise, 0.22  0.03 pA, n = 9,
P = 4.4 9 105; change in holding current, 2.5  1.6 pA,
P = 0.16). At this concentration, THDOC had no effect on
GABAARs underlying synaptic inhibition, as shown by the lack of
any change in sIPSC frequency, amplitude, or kinetics (Fig. 3C;
Table 2). In contrast, zolpidem (50 nM) signiﬁcantly increased
sIPSC peak amplitude and prolonged the decay time (with no effects
on rise time or frequency; Fig. 3D; Table 2). However, consistent
with a lack of effect on extrasynaptic GABAARs underpinning the
tonic conductance (Nusser & Mody, 2002; Mtchedlishvili & Kapur,
2006), zolpidem altered neither RMS noise (Fig. 3B: zolpidem,
3.20  0.32 pA; control, 3.13  0.28 pA; n = 6, P = 0.21) nor the
holding current (zolpidem, 86.0  5.3 pA; control,
88.6  5.1 pA; P = 0.64).
By quantifying the actions of these drugs on tonic inhibition,
from calculating the effect on the GABAAR-mediated component
of the RMS noise (i.e. by normalization to the BIC-sensitive com-
ponent), we found that 50 nM THDOC caused a signiﬁcant increase
in tonic inhibition but had no effect on phasic inhibition (Fig. 3E:
change in tonic inhibition, 73.8  16.9%, P = 0.0012; change in
phasic inhibition, 0.6  9.3%, P = 0.45). In contrast, zolpidem sig-
niﬁcantly increased phasic inhibition (quantiﬁed as the phasic cur-
rent; see Materials and methods), with no change in tonic
inhibition (Fig. 3E: change in phasic inhibition, 84.5  13.8%,
P = 0.04; change in tonic inhibition, 11.8  10.4%, P = 0.31).
Therefore, baseline RMS noise is a sensitive and selective indicator
of changes in the small tonic inhibitory conductances in these
cells.
Activation of PKC decreases tonic GABAAR activity in DGGCs
Previous studies have shown that GABAAR subunits are substrates
for phosphorylation by PKC, and that currents mediated by these
receptors are differentially regulated by this kinase (Krishek et al.,
1994; Lin et al., 1994; Poisbeau et al., 1999; Brandon et al., 2000;
Abramian et al., 2010). We used the speciﬁc PKC activator PMA to
investigate whether PKC regulates tonic GABAA inhibition in
DGGCs. PMA (200 nM) was bath applied to hippocampal slices at
both room and physiological temperatures. To avoid prolonged
application having deleterious effects on slice health, we applied
PMA for either 10 min (room temperature) or 5 min (physiological
temperature) before returning slices to control solution. With this
protocol, PMA initiated a progressive reduction in baseline RMS
noise at both temperatures (Fig. 4A–D). The onset was relatively
fast, with the noise declining 5–10 min after PMA application at
room temperature and after only a few minutes at physiological tem-
perature. Although small, the reductions were signiﬁcant (Table 3:
room temperature, control, 2.60  0.14 pA, at 20 min after PMA
application, 2.26  0.16 pA, equivalent to a 13.6  3.3% reduc-
tion, n = 6, P = 0.014; physiological temperature, control, 3.42 
0.37 pA, at 10 min after PMA application, 2.77  0.28 pA, equiva-
lent to a 13.7  4.3% reduction, n = 9, P = 0.006). Application of
BIC (20 lM) at the end of the recording caused a further decrease in
RMS noise, indicating that there was still a component of the cur-
rent noise mediated by GABAAR activity after the PMA-evoked
reduction (Fig. 4A and C).
CA1
CA3
DG
dLGN
DG
dLGN
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B C
BICDG
dLGN
40 pA
50 s
BIC
Fig. 1. Properties of DGGCs and dLGN relay neurons. (A) Schematic diagram of a coronal mouse brain section, indicating the locations of hippocampal CA1,
CA3 and DG regions, as well as the thalamic dLGN. (B) Confocal images (Z-projections of image stacks) of typical DGGCs (top panel) and dLGN relay neu-
rons (bottom panel). Scale bars: 50 lm. (C) Representative membrane currents from DGGCs (top) and dLGN relay neurons (bottom). BIC (20 lM) reveals the
presence of a tonic GABAAR-mediated conductance, as well as blocking sIPSCs. Insets: all-points histograms in controls (grey) and after BIC application
(black).
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To ensure the accuracy of these measurements, we used several
controls. First, to check that this reduction in RMS noise was medi-
ated via an action on GABAARs, PMA was applied in the presence
of BIC (20 lM) to block all GABAAR activity. Under these condi-
tions, there was no reduction in RMS noise (Table 3: room tempera-
ture, 2.0  3.4% reduction in RMS noise, n = 5, P = 0.59).
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Fig. 2. Properties of tonic and phasic inhibition in DGGCs at room and physiological temperature. (A and B) Membrane currents recorded from DGGCs at
room (A) and physiological (B) temperatures (thermometer symbol). Bicuculline (BIC; bar) blocks the sIPSCs and a steady-state inward current with a reduction
in the baseline noise, revealing the presence of a tonic GABAA receptor-mediated conductance. (C and D) Plots of holding current (black circles) and RMS
noise (grey) for the same experiments depicted in (A) and (B), over the same timescale. (E and F) Scatter plots of changes to holding currents (ΔI) and RMS
noise (ΔRMS) by bicuculline for recordings at room (E) and physiological (F) temperatures. Open symbols and error bars are mean values  SEMs. Linear
regression analyses (dashed lines) illustrate positive correlations between changes in holding current and RMS noise. (G and H) Properties of sIPSCs at room
(G) and physiological (H) temperatures. Average IPSC waveforms were constructed for 10 cells at each temperature (thin lines) along with superimposed global
average IPSC waveforms (bold lines). Scatter plots show the mean values of peak amplitude, decay time and 10–90% rise time for these 10 cells with open
symbols indicating global averages.
Table 1. Properties of IPSCs in DGGCs at room and physiological temperatures
Recording conditions Peak amplitude (pA) 10–90% rise time (ms) Decay time (ms) Frequency (Hz) n
sIPSCs Room temperature (21–23 °C) 17.6  1.6 0.69  0.08 19.0  1.0 1.0  0.2 10
Physiological temperature (34–37 °C) 44.2  2.4 0.28  0.02 5.8  0.2 3.8  0.8 10
mIPSCs Room temperature (21–23 °C) 15.6  1.8 0.34  0.04 11.2  0.9 0.8  0.2 8
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Second, we checked the stability of RMS noise over a prolonged
period in the absence of drugs. Indeed, there were no signiﬁcant
changes in RMS noise at room temperature (normalized noise,
99.8  0.8%, n = 5, P = 0.29) or physiological temperature (nor-
malized noise, 103.5  4.4%, n = 5, P = 0.48) over a period of
25–30 min. Third, we checked whether changes in series resistance
(Rs) could have caused a spurious change in RMS noise during the
recordings with PMA. Reassuringly, Rs remained stable during these
recordings (room temperature, control, 14.7  1.8 MΩ, after PMA
application, 15.1  1.5 MΩ; physiological temperature, control,
12.9  0.9 MΩ, after PMA application, 13.5  0.9 MΩ). There-
fore, the reduction in baseline noise after PMA application repre-
sents a genuine decrease in tonic GABAAR activity.
We then constructed average sIPSC waveforms before and after
PMA application to determine whether there was any effect of PKC
activation on phasic inhibition under our conditions. However, the
amplitude, kinetics and frequency of sIPSCs remained unchanged
following PMA application at both recording temperatures (Fig. 4E
and F; Table 2). However, PKC can affect miniature IPSC (mIPSC)
amplitudes in DGGCs (Poisbeau et al., 1999). Therefore, recordings
were also made in the presence of 500 nM tetrodotoxin to evaluate
the impact of PKC on mIPSCs. Average mIPSC waveforms con-
structed under control conditions at room temperature revealed that
mIPSCs showed a similar peak amplitude and frequency to sIPSCs,
but with faster kinetics (Table 1). After application of PMA
(200 nM), mIPSC frequency and kinetics remained unchanged
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(Table 2), but, consistent with the earlier study, mIPSC peak ampli-
tude was increased (PMA, 18.7  1.9 pA; control,
15.6  1.8 pA; n = 8, P = 0.04).
Inhibition of PKC increases tonic GABAAR activity in DGGCs
We further evaluated the effect of PKC on tonic GABAAR activity
by using a cell-permeable PKC inhibitor, BIS-I. This is widely rec-
ognized and used as a highly effective inhibitor of conventional and
novel PKC isoenzymes, but it can also target other kinases (Wu-
Zhang & Newton, 2013). Bath application of 500 nM BIS-I gradu-
ally increased RMS noise at both room and physiological tempera-
ture (Fig. 5A–D). At room temperature, this effect was apparent
within a few minutes of drug application, in contrast to a slower
onset over a period of 5–10 min at physiological temperature. The
increase in RMS noise became signiﬁcant after 15–20 min (Table 3:
room temperature, control, 3.22  0.31 pA, at 15 min after BIS-I
application, 3.49  0.35 pA, n = 7, P = 0.015; physiological tem-
perature, control, 3.28  0.23 pA, at 15 min after BIS-I application,
3.83  0.40 pA, n = 7, P = 0.01).
Application of BIC at the end of the recording blocked the BIS-I-
evoked increase in noise, and further lowered RMS noise to below
control levels (Fig. 5A and C). Furthermore, pre-application of BIC
blocked the effect of BIS-I (Table 3: room temperature, 0.4  3.9%
increase in RMS noise, n = 9, P = 0.93). As before, series resis-
tance did not account for these changes, remaining stable throughout
(room temperature, control, 15.4  2.0 MΩ, after BIS-I application,
15.7  2.1 MΩ; physiological temperature, control,
12.9  1.0 MΩ, after BIS-I application, 13.0  1.0 MΩ). We also
checked whether BIS-I had any effects on phasic inhibition by con-
structing average sIPSC waveforms. As with the PMA data, there
were no effects on sIPSC parameters at either recording temperature
(Fig. 5E and F; Table 2). Taken overall, these data indicate that the
noise increase evoked by BIS-I is mediated by GABAARs.
PKC regulates tonic GABAAR activity in thalamic dLGN relay
neurons
Thalamic relay neurons within the dLGN express a tonic GABAAR-
mediated conductance that, similar to that of hippocampal DGGCs,
is likely to be mediated by a4bd GABAARs (Cope et al., 2005;
Bright et al., 2007). Given our results with tonic GABA currents in
DGGCs, we next examined whether tonic inhibition in dLGN relay
neurons can be modulated by a similar PKC-dependent mechanism.
Recording from visually identiﬁed relay neurons within the dLGN
at room temperature showed that PMA (200 nM for 10 min) gradu-
ally reduced RMS noise (Fig. 6A and B, Table 3: control,
5.76  0.74 pA; at 20 min after PMA application, 5.13  0.60 pA;
n = 8, P = 0.04). Application of BIC at the end of the recording
revealed that there was still a component of GABAAR-mediated
noise remaining (Fig. 6A). In contrast, inhibition of PKC with BIS-I
caused a slow increase in RMS noise (Fig. 6C and D, Table 3: con-
trol, 5.04  0.59 pA; at 15 min after BIS-I application,
5.73  0.73 pA; n = 8, P = 0.02). As with the DGGC recordings,
BIC subsequently reduced RMS noise to below control levels, indi-
cating that the BIS-I effect is mediated purely by tonic GABAAR
activity (Fig. 6C). Indeed, pre-application of BIC abolished the
changes in noise caused by PMA (0.2  4.4% decrease in RMS
noise, n = 6, P = 0.75) and BIS-I (3.6  1.9% decrease in RMS
noise, n = 5, P = 0.14). Examination of sIPSCs showed that neither
PMA nor BIS-I had any impact on phasic inhibition within these
cells (Fig. 6E and F). As for the DGGCs, control recordings indi-
cated that baseline RMS noise remained stable over a period of
25 min (normalized noise, 103.2  8.4%, n = 5, P = 0.80). Thus,
endogenous PKC activity within dLGN relay neurons is capable of
regulating tonic inhibition in a bidirectional manner, with increased
and decreased PKC function leading to diminished and enhanced
tonic GABAAR activity, respectively.
Modulation of recombinant d subunit-ontaining GABAARs by
protein kinases
Given that tonic GABAAR-mediated inhibition in hippocampal
DGGCs and in thalamic dLGN relay neurons can be modulated in a
similar manner by PKC, it is of interest that tonic inhibition in these
two cell types is likely to be mediated predominantly by the same
extrasynaptic GABAAR subtype, i.e., a4b2d (Pirker et al., 2000;
Cope et al., 2005; Glykys & Mody, 2007; Herd et al., 2008).
To corroborate our ﬁndings from brain slice recordings, we inves-
tigated the modulation by protein kinases of recombinant a4b2d
GABAARs heterologously expressed in HEK293 cells. GABA was
bath applied to reproduce the physiological mode of activation of
Table 2. Effects of drugs on IPSC properties in DGGCs
Recording temperature Peak amplitude (pA) 10–90% rise time (ms) Decay time (ms) Frequency (Hz) n
sIPSCs
Control 17.4  2.6 0.50  0.09 17.3  1.2 0.7  0.3
THDOC 50 nM Room 17.1  2.2 0.58  0.11 16.9  1.7 0.8  0.4 6
Control 41.6  5.6 0.57  0.08 17.4  1.0 1.8  0.4
Zolpidem 50 nM Room 57.7  8.2* 0.57  0.07 23.1  1.3* 1.2  0.2 6
Control 19.1  2.5 0.73  0.10 20.8  1.5 1.0  0.4
PMA 200 nM Room 20.6  3.4 0.63  0.12 21.2  0.9 0.8  0.3 6
Control 44.3  3.6 0.27  0.02 6.3  0.2 2.6  0.6
PMA 200 nM Physiological 46.6  7.2 0.35  0.07 6.4  0.3 2.9  0.6 9
Control 35.5  4.0 0.67  0.11 18.2  1.1 1.4  0.3
BIS-I 500 nM Room 40.9  4.8 0.60  0.11 19.8  0.6 0.9  0.1 7
Control 38.7  4.0 0.36  0.05 7.0  0.6 7.0  1.2
BIS-I 500 nM Physiological 40.9  4.8 0.30  0.02 7.1  0.4 6.8  1.4 7
mIPSCs
Control 15.6  1.8 0.34  0.04 11.2  0.9 0.8  0.2
PMA 200 nM Room 18.7  1.9* 0.32  0.03 12.0  0.5 0.9  0.1 8
Room temperature is 21–23 °C and physiological temperature is 34–37 °C. The only signiﬁcant differences from control conditions are for the peak amplitude
and decay time of sIPSCs in 50 nM zolpidem and for the peak amplitude of mIPSCs in 200 nM PMA. *P < 0.05, paired t-test.
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these extrasynaptic receptors by relatively slowly changing, low con-
centrations of neurotransmitter, and recordings were made at room
temperature (21–23 °C) and near-physiological temperature
(34.5  0.1 °C, n = 85). GABA concentrations were chosen to pro-
vide prolonged, sustained increases in channel activity, similar to
tonic currents in neurons, enabling the co-application of kinase-mod-
ulating drugs. At room temperature, 100 nM GABA caused a signiﬁ-
cant increase in RMS noise that quickly attained a steady state and
remained stable for 20–30 min (Fig. 7A: normalized response,
233.9  48.5% at 5 min after GABA application, 232.4  98.4%
at 25 min after GABA application, n = 6). At physiological temper-
ature, a slightly higher concentration of GABA (300 nM) was
needed to achieve a similar level of sustained activation (Fig. 7B:
normalized response, 282.7  37.7% at 5 min after GABA applica-
tion, 271.3  33.0% at 20 min after GABA application, n = 6).
PMA (200 nM) applied 5 min after GABA did not affect the
GABA-activated noise increase at room temperature (Fig. 7C: nor-
malized response, 245.3  31.1% at 5 min after PMA application,
243.9  34.9% at 20 min after PMA application, n = 9, P = 0.13).
In contrast, at physiological temperature, PMA progressively
reduced the noise evoked by 300 nM GABA (Fig. 7D: normalized
response, 184.5  19.6% at 5 min after PMA application,
141.2  25.0% at 20 min after PMA application, n = 6, equivalent
to a 59.8  13.2% reduction; P = 0.01; Fig. 8F). Hence, activation
of PKC by PMA reduced the activity of a4b2d GABAARs, but only
at physiological temperature.
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The effect of inhibiting PKC on d subunit-containing GABAAR
activity was examined at room and physiological temperatures with
BIS-I (500 nM). However, no effects were observed on GABA-
evoked noise at either temperature (Fig. 8A and B: room tempera-
ture, normalized response, 340.3  20.9% at 5 min after BIS-I
application, 320.9  16.7% at 20 min after BIS-I application,
n = 6, P = 0.16; physiological temperature, normalized response,
380.3  25.4% at 5 min after BIS-I application, 338.5  25.2% at
20 min after BIS-I application, n = 6, P = 0.13).
To establish that the large reduction in noise seen with PMA was
caused by a direct effect on PKC and not by a non-speciﬁc effect
on the a4b2d GABAAR, we co-applied PMA with BIS-I at physio-
logical temperature (Fig. 8C). Under these conditions, the PMA
effect was blocked (normalized response, 400.6  53.1% at 5 min
after PMA and BIS-I co-application, 360.7  39.1% at 20 min after
drug application, n = 7, P = 0.21), suggesting that the PMA effect
is mediated by activation of endogenous PKC in HEK cells.
The function and trafﬁcking of GABAARs can be modulated by
phosphorylation of key residues, mainly within the intracellular loops
of b1–3 and c2 subunits (Moss & Smart, 1996; Kittler & Moss,
2003). A conserved serine in receptor b subunits (Ser409 in b1 and
b3; Ser410 in b2) is particularly important for modulation by PKC
(Kittler & Moss, 2003). To assess whether Ser410 is involved in the
PMA effect seen here, we expressed abd GABAARs containing a
mutated b2 subunit where Ser410 is replaced with a non-phosphory-
lated alanine, b2S410A. Importantly, activation of a4b2S410Ad
GABAARs by 300 nM GABA at physiological temperature evoked
similar changes in holding current and RMS noise to those seen with
wild-type a4b2d GABAARs (GABA-activated current, a4b2
S410Ad,
–137.5  23.9 pA, n = 7, a4b2d, –124.2  20.4 pA, n = 6,
P = 0.68; GABA-activated RMS noise, a4b2S410Ad,
9.50  1.15 pA, n = 7, a4b2d, 8.30  0.67 pA, n = 6, P = 0.39;
unpaired t-tests with Welch correction), suggesting that functional
receptor expression is not altered by the serine mutation. Applying
PMA to a4b2S410Ad GABAARs failed to affect the current noise
evoked by 300 nM GABA (Fig. 8D: normalized response,
294.4  29.0% at 5 min after PMA application, 300.7  8.5% at
15 min after PMA application, n = 7, P = 0.4). This strongly indi-
cates that the PMA-dependent decrease in noise is caused by upregu-
lation of PKC activity that leads to increased phosphorylation at
Ser410 on b2 subunits.
A novel site on the a4 subunit, Ser443, has also been identiﬁed
as an important substrate for PKC modulation of recombinant a4b3
GABAARs (Abramian et al., 2010). We tested the involvement
of this residue by expressing GABAARs containing a mutated a4
subunit where Ser443 is replaced by an alanine, a4S443A. Introduc-
tion of this mutation had no apparent effect on receptor function
and expression, as 300 nM GABA-evoked current and noise at
physiological temperature was comparable to that observed with
wild-type a4b2d GABAARs (GABA-activated current, a4
S443Ab2d,
–157.4  19.4 pA, n = 7, a4b2d, –124.2  20.4 pA, n = 6,
P = 0.27; GABA-activated RMS noise, a4S443Ab2d,
6.56  0.68 pA, n = 7, a4b2d, 8.30  0.67 pA, n = 6, P = 0.1;
unpaired t-tests with Welch correction). Application of 200 nM
PMA to a4S443Ab2d GABAARs resulted in a progressive decline in
GABA-evoked noise, similar to that seen with wild-type GABAARs
(Fig. 8E: normalized response, 196.1  11.9% at 5 min after PMA
application, 165.0  12.5% at 20 min after PMA application,
n = 7, P = 0.01). Normalization to the GABA-evoked response
showed that PMA caused a 41  12.3% reduction, which was simi-
lar to that seen with wild-type GABAARs (Mann–Whitney,
P = 0.25; Fig. 8F). This indicates that, for the a4b2d GABAAR
used here, PKC-mediated phosphorylation of a4S443A is unlikely to
play a role in the PMA-dependent decrease in GABA-evoked noise.
Activation of PKC reduces surface expression of recombinant
d subunit-containing GABAARs
The PMA-evoked reduction in d subunit GABAAR activity could be
caused by inhibition of channel function and/or a decrease in surface
receptor expression. To address this issue, we used live imaging of
HEK293 cells expressing a4b2d–SEP GABAARs. The SEP moiety
is a variant of green ﬂuorescent protein that shows pH-sensitive ﬂu-
orescence, showing very little emission at pH < 6.0 (Ashby et al.,
2004). Hence, SEP-tagged proteins show bright ﬂuorescence at the
cell surface, but limited ﬂuorescence in intracellular compartments,
where the pH is lower. HEK293 cells expressing a4b2d–SEP
GABAARs were imaged at 30–32 °C, during bath application of
GABA (300 nM), followed by co-application of PMA (200 nM).
Application of PMA caused a progressive reduction in cell surface
ﬂuorescence that appeared to plateau after 15–20 min (Fig. 9A and
B: normalized ﬂuorescence at t = 20 min, 86.1  3.3%, n = 10,
P = 0.004). In contrast, during control experiments in which GABA
was applied alone, surface ﬂuorescence remained stable (Fig. 9B:
normalized ﬂuorescence at t = 20 min, 102.3  2.8%, n = 10,
P = 0.31). Surface ﬂuorescence could be quenched by bath applica-
tion of a pH 4.5 solution (Fig. 9C). Therefore, PMA-evoked activa-
tion of PKC causes a decrease in cell surface expression of a4b2d
GABAARs that correlates well with the reduction in channel activity
observed during current recordings.
Table 3. RMS noise for DGGCs and dLGN relay neurons
Cell type Treatment Recording temperature Control (pA) Drug (pA) BIC (pA) n
DGGC PMA Room 2.60  0.14 2.26  0.16* 1.77  0.16* 6
Physiological 3.42  0.37 2.77  0.28* 2.08  0.12* 9
BIS-I Room 3.22  0.31 3.49  0.35* 2.43  0.28* 7
Physiological 3.28  0.23 3.83  0.40* 2.87  0.27* 7
PMA in BIC Room 2.45  0.23 2.33  0.9 – 5
BIS-I in BIC Room 2.25  0.10 2.26  0.11 – 9
dLGN PMA Room 5.76  0.74 5.13  0.60* 2.90  0.23* 8
BIS-I Room 5.04  0.59 5.73  0.73* 3.38  0.31* 8
PMA in BIC Room 3.36  0.27 3.40  0.37 – 6
BIS-I in BIC Room 3.17  0.25 3.06  0.24 – 5
Control measurements were made just prior to drug application, drug measurements were made 15–20 min after drug application, and BIC measurements were
made 4–5 min after BIC application. For the BIC pre-application experiments, the control value was measured in BIC just prior to drug application.
*P < 0.05 (paired t-test), signiﬁcant differences as compared with control values.
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Discussion
DGGCs play a vital role in hippocampal information processing by
ﬁltering out synchronous excitatory activity and preventing the gen-
eration of seizures in downstream hippocampal structures (Heine-
mann et al., 1992). Key to this role is the low excitability of these
cells, part of which is derived from the efﬁcacy and timing of
GABA-mediated inhibition in the DG (Coulter & Carlson, 2007). In
comparison, thalamic relay neurons within the dLGN process visual
inputs from the retina, before passing this information onto the cor-
tex. Inhibitory input to these cells is critically involved in visual
information processing, modulation of receptive ﬁeld properties,
signal selectivity, information encoding, and spike ﬁring mode
behaviour (Hubel & Wiesel, 1961; Sillito & Kemp, 1983; Holdefer
et al., 1989; Wang et al., 2007, 2011). Both dentate and thalamic
cell types express populations of synaptic and extrasynaptic
GABAARs to provide phasic and tonic inhibition (Nusser & Mody,
2002; Cope et al., 2005; Coulter & Carlson, 2007). The tonic com-
ponent is considered to be a key regulator of excitability in both
neuronal populations (Nusser & Mody, 2002; Cope et al., 2005;
Maguire et al., 2005; Bright et al., 2007; Coulter & Carlson, 2007).
Thus, elucidating how tonic inhibition is temporally modulated is
important for understanding information processing in the hippocam-
pus and thalamus.
To explore whether tonic inhibition can be dynamically regulated,
we used slice preparations from older animals in which the molecular
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components underpinning GABAergic transmission, including those
controlling GABA release, postsynaptic receptor expression, and
GABA uptake, have matured. Recording temperature affects both
GABA release and GABA uptake, and is therefore vital for setting
the extent of tonic inhibition (Glykys & Mody, 2007); hence, record-
ings were performed at both room temperature (21–23 °C) and phys-
iological temperature (35–37 °C). The concentration of GABA
within the slice is another key determinant of tonic GABA current,
and some investigators add extra GABA or GABA uptake blockers
to boost the tonic current amplitude. However, we did not do this,
because: increased GABA levels may recruit additional populations
of receptors (Scimemi et al., 2005); GABA uptake as such is vital
for regulating tonic GABA currents within these cells (Nusser &
Mody, 2002; Cope et al., 2009); and extrasynaptic GABAARs are
strongly desensitized when exposed to increasing ambient GABA
levels (Mortensen et al., 2010; Bright et al., 2011). Thus, although
we have adopted a ‘physiological’ approach, it confers a disadvan-
tage in that tonic current amplitudes are relatively small, particularly
in the DG at room temperature (8.6  2.1 pA, n = 22). To obviate
this, we used changes to RMS baseline noise to reliably monitor
tonic inhibition. This approach was validated with zolpidem and
THDOC to selectively potentiate the function of synaptic c2 and
extrasynaptic d subunit-containing GABAARs, respectively (Nusser
& Mody, 2002; Stell et al., 2003). Consistent with their selectivity,
zolpidem increased the peak amplitude and decay time of sIPSCs
without affecting RMS noise, whereas THDOC only increased the
RMS noise. Thus, drugs that potentiated (THDOC) and inhibited
(BIC) extrasynaptic GABAARs increased and reduced RMS noise,
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bar charts showing the lack of effect on sIPSC parameters (peak amplitude, 10–90% rise time, decay time and frequency).
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respectively, with a sensitivity that could not be matched by measur-
ing holding currents alone. Therefore, we can be conﬁdent that, in
our system, changes in RMS noise are positively correlated with
changes in extrasynaptic GABAAR activity.
With the use of RMS noise, the selective activation of PKC was
shown to decrease tonic GABAAR activity in DGGCs at both room
and physiological temperature. In contrast, increased tonic receptor
activity was apparent after inhibition of PKC with BIS-I. In both
cases, no effects were observed on phasic inhibition in the form of
sIPSCs. However, consistent with a previous study using intracellu-
lar application of PKC in DGGCs, we saw an increase in the peak
amplitude of mIPSCs after PMA application (Poisbeau et al., 1999).
It is unclear why we observed an effect of PKC activation on the
amplitude of mIPSCs, but not sIPSCs, although the earlier study
would suggest a postsynaptic effect, probably via enhanced receptor
function. The differential modulation of the two forms of inhibition
(tonic and phasic) could be attributable to the expression of different
b subunit isoforms in the underlying receptor populations. Herd
et al. (2008) reported that synaptic receptors are likely to contain b3
(and possibly b1) subunits, whereas the benzodiazepine-insensitive
extrasynaptic d subunit-containing GABAARs mediating the major-
ity of tonic inhibition probably contain the b2 subunit. As it has
been shown that the identity of the b subunit is critical for phospho-
dependent regulation (McDonald et al., 1998; Nusser et al., 1999;
Brandon et al., 2003; Houston et al., 2007), differential b subunit
expression may be responsible for the disparate regulation of tonic
and phasic inhibition that we observed here.
Our investigation of tonic inhibition in dLGN relay neurons
revealed similar phospho-dependent modulation, with PKC activa-
tion and inhibition causing decreases and increases, respectively, in
extrasynaptic GABAAR activity, without affecting phasic inhibition.
Although the available evidence does not unequivocally identify the
GABAAR populations within this nucleus, it appears likely that syn-
aptic a1b2c2 and extrasynaptic a4b2d GABAARs are expressed.
This deduction is based on both immunohistochemical data (Sur
et al., 1999; Pirker et al., 2000) and pharmacological characteriza-
tion of GABAAR-mediated currents in the dLGN and ventrobasal
thalamus (Belelli et al., 2005; Cope et al., 2005; Peden et al.,
2008). Therefore, the b2 subunit appears to be common among tha-
lamic GABAARs, suggesting that the differential regulation of tonic
and phasic inhibition in the dLGN by PKC cannot be attributable to
variant b subunits. As the extrasynaptic a4b2d GABAAR appears to
be common to both DGGCs and dLGN relay neurons, we used het-
erologous expression of recombinant receptors to investigate the
underlying mechanisms of PKC regulation of tonic inhibition. These
experiments demonstrated that PKC activation reduced a4b2d
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Fig. 7. Temperature-dependent modulation of recombinant a4b2d GABAARs by PKC. (A) Whole-cell recordings from HEK293 cells expressing a4b2d
GABAARs. Bath application of a low concentration of GABA (100 nM) was used to reproduce the physiological mode of activation of native GABAARs. RMS
noise was averaged over 60-s epochs, and then normalized to the epoch just prior to GABA application. Pooled data from all cells recorded at room temperature
(n = 6) show a sustained increase in RMS noise produced by 100 nM GABA. (B) At physiological temperature, 300 nM GABA was used to activate a4b2d
GABAARs. Pooled data (n = 6), normalized as above, show that this concentration of GABA led to a similar level of sustained activation as 100 nM GABA at
room temperature. (C) PMA was applied 5 min after GABA application. Pooled normalized data (n = 9) show that PMA (200 nM) had no effect on the RMS
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GABAAR activity at physiological temperature, while having no
effect at room temperature. Live cell imaging of a4b2d–SEP
GABAARs showed that this reduction was correlated with a
decrease in receptor surface expression, indicating that PKC activa-
tion causes a change in the trafﬁcking of extrasynaptic GABAARs.
In contrast, inhibition of PKC activity had no effect on a4b2d
GABAAR-mediated noise at either temperature.
Although very few studies have recorded from HEK293 cells at
physiological temperatures, one report highlights the importance of
temperature for PKC modulation of recombinant GABAARs (Machu
et al., 2006). In this earlier study, PMA was ineffective in modulat-
ing currents mediated by a1b2c2 GABAARs at room temperature,
but caused a decrease in function at physiological temperature
(35 °C), similar to the effects shown here with a4b2d GABAARs.
This, combined with our observation that BIS-I is ineffective at both
temperatures, suggests that basal PKC activity is low at both tem-
peratures, but can be enhanced by application of a phorbol ester at
physiological temperature. Although the results obtained with the
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expression system show a contrasting temperature dependence to
that shown by the brain slice data, it is perhaps not surprising that
the phosphorylation state of the receptor, which will depend upon
the concerted action of various kinases and phosphatases, shows dif-
ferential regulation.
Interestingly, PKC can also phosphorylate Ser443 on the a4 sub-
unit, which enhances the surface stability of a4b3 GABAARs and
prevents the run-down of GABA-activated currents in HEK293
cells (Abramian et al., 2010). This effect relies on phosphorylation
of Ser408 and/or Ser409 in the b3 subunit (Comenencia-Ortiz
et al., 2010), and suggests that PKC-mediated phosphorylation can
enhance GABA-mediated tonic currents, in contrast to the effects
that we observed. However, this apparent disparity may be
accounted for by the differential regulation of a4 subunit phosphor-
ylation in b2 and b3 subunit-containing GABAAR, and further
raises the intriguing possibility that PKC-evoked plasticity of tonic
inhibition may be bidirectional, depending on the b subunit identity
in the GABAAR. Our recombinant receptor data indicated that
phosphorylation at b2 Ser410 was necessary for the PKC-evoked
decrease in d subunit-containing GABAAR activity, as removing
the primary site for PKC phosphorylation on the b2 subunit
(a4b2S410Ad) ablated the PMA-evoked decrease in tonic current. In
contrast, our recordings from a4S443Ab2d GABAARs show that the
decrease in tonic activity triggered by PMA is the same as in
wild-type GABAAR, suggesting that phosphorylation at a4 Ser443
is dispensable for the PKC regulation of a4b2d GABAAR seen
here.
This is the ﬁrst study to examine the concurrent regulation of
GABAAR-mediated tonic and phasic inhibition within a brain slice
preparation under physiological conditions of temperature and ambi-
ent GABA levels. Our results show that the tonic inhibition mediated
by a4b2d GABAARs is modulated in a similar way by PKC-depen-
dent phosphorylation in both the hippocampus and the thalamus,
whereas phasic inhibition appears to be insensitive. Although the
effects of phospho-modulatory drugs on tonic inhibition appear to be
small (10–20% changes in the total RMS noise), this may partly
reﬂect the recording conditions (no added GABA or uptake block-
ers). Nevertheless, modest changes in an inhibitory conductance that
is continuously active are likely to have an important impact on neu-
ronal excitability (Mitchell & Silver, 2003; Bright et al., 2007; Jia
et al., 2008; Song et al., 2011). Our study further suggests that sig-
nalling pathways that converge on PKC activation could, in princi-
ple, lead to long-term changes in the efﬁcacy of tonic inhibition,
indicating that this important form of regulation of neuronal excit-
ability is indeed subject to dynamic plasticity-based modulation.
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